Ajai Chari

10 Podcast Episodes

Studying the Promising Role of Bispecific Antibodies in Multiple Myeloma With Ajai Chari, MD

Studying the Promising Role of Bispecific Antibodies in Multiple Myeloma With Ajai Chari, MD

This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting ... Read more

21 Jan 2023

8mins

Key Presentations on Multiple Myeloma from ASH 2021 with Dr Ajai Chari

Key Presentations on Multiple Myeloma from ASH 2021 with Dr Ajai Chari

Dr Ajai Chari from the Tisch Cancer Institute Clinical Trials Office in New York discusses recent therapeutic advances i... Read more

10 Mar 2022

40mins

Similar People

Clinical Cases: MRD in Real-World Clinical Practice - Gail J. Roboz, MD; Ajai Chari, MD; Steven Coutre, MD; Prashant Kapoor, MD; Aaron C. Logan, MD, PhD

Clinical Cases: MRD in Real-World Clinical Practice - Gail J. Roboz, MD; Ajai Chari, MD; Steven Coutre, MD; Prashant Kapoor, MD; Aaron C. Logan, MD, PhD

MRD in Hematologic Malignancies: Testing Considerations and Challenges

Multiple Myeloma - Ajai Chari, MD

Multiple Myeloma - Ajai Chari, MD

MRD in Hematologic Malignancies: Testing Considerations and Challenges

22 Jan 2020

19mins

Most Popular

Multiple Myeloma - Ajai Chari, MD

Multiple Myeloma - Ajai Chari, MD

MRD in Hematologic Malignancies: Testing Considerations and Challenges

22 Jan 2020

19mins

Clinical Cases: MRD in Real-World Clinical Practice - Gail J. Roboz, MD; Ajai Chari, MD; Steven Coutre, MD; Prashant Kapoor, MD; Aaron C. Logan, MD, PhD

Clinical Cases: MRD in Real-World Clinical Practice - Gail J. Roboz, MD; Ajai Chari, MD; Steven Coutre, MD; Prashant Kapoor, MD; Aaron C. Logan, MD, PhD

MRD in Hematologic Malignancies: Testing Considerations and Challenges

Antibodies in Practice: SLAMF-7, CD38, Bispecific? Updates: Should They be Used Upfront? - Ajai Chari, MD

Antibodies in Practice: SLAMF-7, CD38, Bispecific? Updates: Should They be Used Upfront? - Ajai Chari, MD

Multiple Myeloma: Treatment Challenges and Updates

20 Dec 2019

22mins

Antibodies in Practice: SLAMF-7, CD38, Bispecific? Updates: Should They be Used Upfront? - Ajai Chari, MD

Antibodies in Practice: SLAMF-7, CD38, Bispecific? Updates: Should They be Used Upfront? - Ajai Chari, MD

Multiple Myeloma: Treatment Challenges and Updates

20 Dec 2019

22mins

Ajai Chari, MD: DEBATE: Is MRD the new primary goal for multiple myeloma treatment? - No

Ajai Chari, MD: DEBATE: Is MRD the new primary goal for multiple myeloma treatment? - No

Webcast: Looking for One in a Million: Is MRD the New Primary Goal for Multiple Myeloma Treatment?

31 Oct 2018

14mins

Ajai Chari, MD: DEBATE: Is MRD the new primary goal for multiple myeloma treatment? - No

Ajai Chari, MD: DEBATE: Is MRD the new primary goal for multiple myeloma treatment? - No

Webcast: Looking for One in a Million: Is MRD the New Primary Goal for Multiple Myeloma Treatment?

31 Oct 2018

14mins

“Podium: AI tools for podcasters. Generate show notes, transcripts, highlight clips, and more with AI. Try it today at https://podium.page”